Cargando…
Osteoclasts secrete leukemia inhibitory factor to promote abnormal bone remodeling of subchondral bone in osteoarthritis
BACKGROUND: Osteoarthritis (OA) is a common chronic degenerative joint disease. At present, there is no effective treatment to check the progression of osteoarthritis. Osteochondral units are considered to be one of the most important structures affecting the occurrence and development of osteoarthr...
Autores principales: | Zhao, Xin, Ma, Long, Guo, Haohui, Wang, Jian, Zhang, Shuai, Yang, Xiaochun, Yang, Lvlin, Jin, Qunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790929/ https://www.ncbi.nlm.nih.gov/pubmed/35078447 http://dx.doi.org/10.1186/s12891-021-04886-2 |
Ejemplares similares
-
Dihydroartemisinin attenuates osteoarthritis by inhibiting abnormal bone remodeling and angiogenesis in subchondral bone
por: Ma, Long, et al.
Publicado: (2021) -
Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway
por: Guo, Haohui, et al.
Publicado: (2021) -
β2-Adrenergic receptor expression in subchondral bone of patients with varus knee osteoarthritis
por: Yang, Xiaochun, et al.
Publicado: (2022) -
Sclerostin expression in the subchondral bone of patients with knee osteoarthritis
por: Wu, Long, et al.
Publicado: (2016) -
Subchondral bone remodelling and osteoarthritis
por: Román-Blas, Jorge A, et al.
Publicado: (2012)